Molecule
Technetium tc-99m exametazime is a radioactive diagnostic agent indicated for leukocyte (white blood cell) labeled scintigraphy as an adjunct in the localization of intra-abdominal infection and inflammatory bowel disease. MedsAcross supplies Technetium tc-99m exametazime for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
Drax Exametazime is indicated for leukocyte (white blood cell) labeled scintigraphy as an adjunct in the localization of intra-abdominal infection and inflammatory bowel disease. Drax Exametazime is a radioactive diagnostic agent indicated for leukocyte (white blood cell) labeled scintigraphy as an adjunct in the localization of intra-abdominal infection and inflammatory bowel disease.
Source: US FDA prescribing information
When technetium Tc 99m pertechnetate is added to exametazime in the presence of stannous reductant, a lipophilic technetium Tc 99m complex is formed. This lipophilic complex is the active moiety. The lipophilic technetium Tc 99m exametazime complex is taken up and retained in leukocytes.
Source: US FDA prescribing information
Use careful handling with appropriate safety measures to minimize radiation exposure to both patients and healthcare professionals. For an adult patient, recommended dose is 259 - 925 megabecquerels (MBq) [7-25 millicuries (mCi)].
Source: US FDA prescribing information
None. None.
Source: US FDA prescribing information
Hypersensitivity Reactions: Hypersensitivity reactions, including serious signs and symptoms of anaphylaxis, following administration of Tc 99m labeled leukocytes prepared using Tc 99m exametazime have been reported. Always have cardiopulmonary resuscitation equipment and personnel available and monitor all patients for hypersensitivity reactions.
Source: US FDA prescribing information
The following adverse reactions are described elsewhere in the labeling, Hypersensitivity reactions. The following adverse reactions associated with the use of technetium Tc 99m exametazime have been identified in clinical trials or post-marketing reports. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Cardiovascular: transient blood pressure increase Skin and subcutaneous tissue disorders: rash, generalized erythema, urticaria, angioedema, pruritus. General disorders and administration site conditions: facial edema, fever, asthenic conditions (e.g., malaise, fatigue). Nervous system disorders: headache, dizziness, paraesthesia. Vascular disorders: flushing. Gastrointestinal disorders: nausea, vomiting.
Source: US FDA prescribing information
Store Drax Exametazime kit at 15°C - 25°C (59°F - 77°F). Store and dispose of technetium Tc 99m exametazime in compliance with the appropriate regulations of the government agency authorized to license the use of this radionuclide.
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
2 presentations of Technetium tc-99m exametazime, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Ceretec 0.5 mg/5 mL powder for injectionIntravenous | GE Healthcare | US FDA | Available on request |
| Drax Exametazime 0.5 mg powder for injectionIntravenous | Jubilant RadiopharmaIndia | US FDA | Available on request |
2 brand names across 1 markets.
United States
Indian manufacturers are highlighted.
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | Not recorded | — |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Yes, on request. MedsAcross lists 2 presentations of Technetium tc-99m exametazime and sources them for licensed hospitals, importers and physicians against valid import documents. Indian manufacturers include Jubilant Radiopharma.
The catalogue lists 2 brand names for Technetium tc-99m exametazime, including Ceretec, Drax Exametazime.
No listed presentation of Technetium tc-99m exametazime is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Technetium tc-99m exametazime is classified under ATC code V09AA01 (Technetium tc-99m exametazime).
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.